- Senior Vice President of Small Molecule Drug Discovery, Genentech
Wendy has decades of chemistry and drug discovery experience and most recently held the role of SVP, Small Molecule Drug Discovery at Genentech focused on portfolio and technology management. At Genentech, Wendy led research activities and oversaw 900 internal and external multi-disciplinary scientists engaged in drug discovery. Prior to Genentech, Wendy held drug discovery roles at SCIOS, a Johnson & Johnson Company, and Celera Genomics. Wendy led the development of a chemistry campaign against Bruton’s tyrosine kinase, leading to molecules to potentially treat rheumatoid arthritis and B-cell lymphomas. Her team developed fenebrutinib, currently in Phase III trials for several autoimmune disorders.